Clostridium Difficile Infection: The Effects of Acid Suppression Therapy in Patients With Cancer.
BACKGROUND
Clostridium difficile infection (CDI) is common among hospitalized patients and is particularly serious in patients with cancer. Acid suppression therapy, particularly that which uses proton pump inhibitors (PPIs), has been shown to place hospitalized adult patients at greater risk for CDI, but this relationship has not been proven among patients with cancer.


OBJECTIVES
This review assesses risk factors for CDI among patients with cancer, with a specific focus on acid suppression therapy using PPIs and histamine-2 receptor antagonists (H2RAs).


METHODS
A literature search was performed using four electronic databases.


FINDINGS
CDI increases morbidity and mortality in patients with cancer and interferes with their active treatment plans. PPIs and H2RAs increase the risk of developing CDI among patients with cancer, but PPIs carry a higher risk. Other risk factors include antibiotics, transplantation, and chemotherapy.
['Lan|Hannah|H|']
D003015:Clostridium Infections D006801:Humans D015994:Incidence D009369:Neoplasms D054328:Proton Pump Inhibitors
Clostridium difficile infection acid suppression therapy PPIs H2RAs prevention